Skip to main content
SpringerLink
Log in

Mechlorethamine

  • Chapter
Single Agents in Cancer Chemotherapy

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rhoads, C. Report on a cooperative study of nitrogen mustard (HN2) therapy of neoplastic disease. Trans Assoc Amer Phys 60: 110, 1948.

    Google Scholar 

  2. Zanes, R., Doan, C., and Hoster, H. Studies in Hodgkin’s syndrome. VII. Nitrogen mustard therapy. J Lab Clin Med 33: 1002, 1948.

    PubMed  Google Scholar 

  3. Wintrobe, M., and Huguley, C. Nitrogen-mustard therapy for Hodgkin’s disease, lymphosarcoma, the leukemias, and other disorders. Cancer 1: 357, 1948.

    Article  PubMed  CAS  Google Scholar 

  4. Karnofsky, D., Abelmann, W., Craver, L., et al. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1: 634, 1949.

    Article  Google Scholar 

  5. Burchenal, J., Myers, W., Craver, L., et al. The nitrogen mustards in the treatment of leukemia. Cancer 2: 1, 1949.

    Article  PubMed  CAS  Google Scholar 

  6. Erf, L., and Bauer, R. The clinical effect of nitrogen mustard on Hodgkin’s disease. Amer J Clin Path 19: 372, 1949.

    CAS  Google Scholar 

  7. Ariel, I., and Kanter, L. Nitrogen mustard therapy. Amer J Surg 77: 509, 1949.

    Article  PubMed  CAS  Google Scholar 

  8. Dameshek, W., Weisfuse, L., and Stein, T. Nitrogen mustard therapy in Hodgkin’s disease. Analysis of fifty consecutive cases. Blood 4: 338, 1949.

    CAS  Google Scholar 

  9. Bierman, H., Shimkin, M., Mettier, S., et al. Methyl-bis (ß-chloroethyl) amine in large doses in the treatment of neoplastic diseases. Calif Med 71: 117, 1949.

    PubMed  CAS  Google Scholar 

  10. Spurr, C., Smith, T., Block, M., et al. The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias. Amer J Med 8: 710, 1950.

    Article  PubMed  CAS  Google Scholar 

  11. Gellhorn, A., and Collins, V. A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin’s disease. Ann Intern Med 35: 1250, 1951.

    PubMed  CAS  Google Scholar 

  12. Levine, B., and Weisberger, A. The response of various types of bronchogenic carcinoma to nitrogen mustard. Ann Intern Med 42: 1089, 1955.

    PubMed  CAS  Google Scholar 

  13. Hatch, H., Bradford, J., and Ochsner, A. Nitrogen mustard in treatment of advanced carcinoma of the lung. Analysis of 198 cases. JAMA 160: 1129, 1956.

    CAS  Google Scholar 

  14. Coonrad, E., and Rundles, R. Mustard chemotherapy in ovarian carcinoma. Ann Intern Med 50: 1449, 1959.

    PubMed  CAS  Google Scholar 

  15. VACCSG. A clinical study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin’s disease, lymphosarcoma and melanoma. J Nat Cancer Instit 22: 433, 1959.

    Google Scholar 

  16. Zubrod, C., Schneiderman, M., Frei, E., et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 11: 7, 1960.

    Article  Google Scholar 

  17. Hurley, J., and Ellison, E. Chemotherapy of solid cancer arising from the gastro-intestinal tract. Ann Surg 152: 568, 1960.

    Article  PubMed  CAS  Google Scholar 

  18. Hurley, J., Ellison, E., Riesch, J., et al. Chemotherapy of solid carcinoma. JAMA 174: 1696, 1960.

    Article  CAS  Google Scholar 

  19. Laszlo, J., Grizzle, J., Jonsson, U., et al. Comparative study of mannitol mustard, cyclophosphamide, and nitrogen mustard in malignant lymphomas. Cancer Chemother Rep 16: 247, 1962.

    PubMed  CAS  Google Scholar 

  20. Spear, P., and Patno, M. A comparative study of the effectiveness of HN2 and cyclophospahmide in bronchogenic carcinoma, Hodgkin’s disease, and lymphosarcoma. Cancer Chemother Rep 16: 413, 1962.

    PubMed  CAS  Google Scholar 

  21. Scott, J. The effect of nitrogen mustard and maintenance chlorambucil in the treatment of advanced Hodgkin’s disease. Cancer Chemother Rep 27: 27, 1963.

    PubMed  CAS  Google Scholar 

  22. Barran, K., Helm, W., and King, D. Bronchial carcinoma treated with nitrogen mustard and cyclophosphamide. Brit Med J 2: 685, 1965.

    Article  PubMed  CAS  Google Scholar 

  23. Boggs, D., Sofferman, S., Wintrobe, M., et al. Factors influencing the duration of survival of patients with chronic lymphocytic leukemia. Amer J Med 40: 243, 1966.

    Article  PubMed  CAS  Google Scholar 

  24. Decker, D., Malkasian, G., Mussey, E., et al. Cyclophosphamíde: evaluation in recurrent and progressive ovarian cancer. Amer J Obstet Gynec 97: 656, 1967.

    Google Scholar 

  25. Smith, J., Rutledge, F., Burns, B., et al. Systemic chemotherapy for carcinoma of the cervix. Amer J Obstet Gynec 97: 800, 1967.

    PubMed  CAS  Google Scholar 

  26. Sullivan, M. Cyclophosphamide therapy for children with generalized lymphoma and Hodgkin’s disease. Cancer Chemother Rep 51: 393, 1967.

    Google Scholar 

  27. Jacobs, E., Peters, F., Luce, J., et al. Mechlorethamine HC1 and cyclophosphamide in the treatment of Hodgkin’s disease and the lymphomas. JAMA 203: 392, 1968.

    Article  CAS  Google Scholar 

  28. Ezdinli, E., and Stutzman, L. Vinblastine vs nitrogen mustard therapy of Hodgkin’s disease. Cancer 22: 473, 1968.

    Article  PubMed  CAS  Google Scholar 

  29. Green, R., Humphrey, E., Close, H., et al. Alkylating agents in bronchogenic carcinoma. Amer J Med 46: 516, 1969.

    Article  PubMed  CAS  Google Scholar 

  30. Gold, G., Shnider, B., Salvin, G., et al. The use of mechlorethamine, cyclophosphamide, and uracil mustard in neoplastic disease: a cooperative study. J Clin Pharmacol New Drugs 10: 110, 1970.

    CAS  Google Scholar 

  31. Moores, R. Comparison of combination therapy vs nitrogen mustard in Hodgkin’s disease. Proc Amer Assoc Cancer Res 11: 58 (#227), 1970.

    Google Scholar 

  32. Papac, R., and Wood, D. Long term results achieved with the use of alkylating agents in malignant lymphoma and Hodgkin’s disease. Acta Un Int Contra Cancer 20: 377, 1964.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, Bethesda, Maryland, USA

    Robert B. Livingston & Stephen K. Carter

Authors
  1. Robert B. Livingston
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen K. Carter
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1970 IFI/Plenum · New York-Washington-London

About this chapter

Cite this chapter

Livingston, R.B., Carter, S.K. (1970). Mechlorethamine. In: Single Agents in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1378-6_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-1378-6_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-1380-9

  • Online ISBN: 978-1-4684-1378-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation